The Litigation Daily RSS

Litigators at Latham & Watkins and Quinn Emanuel both expect the drastic uptick in special purpose acquisition company deal activity to spawn lawsuits. Here's where they see the fault lines.

The court reversed and remanded a disability rights case over closed captioning on videos that could become one of the first in which a plaintiff seeks damages for past harm based on an inaccessible website. But it's Judge Kevin C. Newsom's concurring opinion on standing that has lawyers paying...

Read the whole entry... »

"We can easily mobilize a team to 'parachute into' any local jurisdiction in the U.S. and prepare for trial under significant time constraints, combining local talent with national expertise," Cohen says.

Glenn Kurtz, the global head of commercial litigation at White & Case, and partner Claudine Columbres got a two paragraph ruling from the Delaware Supreme Court this week that brought an end to four years of high stakes litigation between the two health insurance giants.

Featuring big wins from Baker Botts, Aylstock, Witkin, Kreis & Overholtz, Quinn Emanuel, Wilmer, and more.

When Independent Sports & Entertainment LLC sued Butler last year seeking a portion of the proceeds from a $5 million Nike endorsement contract, his lawyer Mathew Rosengart didn't just play defense.

"I really had this vision that I wanted to use the practice of law to make a difference in a way that was important to me and to find ways to help regular people," says Walsh. "With the global pandemic and being about to turn 50, I realized that if I'm ever going to make a course correction, now...

Read the whole entry... »

Responding to Roberts on Tuesday, DOJ's Eric Feigin said: "Well, your honor, I don't know that we have a specific set of procedures or guidelines that I could kind of publicly share."

"One of the most beneficial trends we have seen post pandemic is the flight of private equity firms from the Northeast and West Coast relocating or establishing substantial outposts in South Florida," said Greenberg Traurig's Michael N. Kreitzer.

Quinn's Andrew Rossman won a ruling from the Delaware Chancery Court late last year allowing a client to walk away from a deal. Last week he got a ruling forcing Kohlberg & Co. to go through with its acquisition of a company that sells cake decorations and technology for use in grocery store...

Read the whole entry... »

How long to clear the case backlog? Judge Inna Klein said, "My guess is between two and four years, and that's just looking at statistics and how many new cases came in this year and projecting that the next years will be about the same."

For the third time in three years, the Supreme Court is asking the solicitor general whether it's time to revisit Section 101 of the Patent Act, this time in an automotive engineering case. Eligibility is one of the most controversial areas of patent law.

Kenneth Polite, a white-collar partner at Morgan, Lewis & Bockius, also disclosed work that included advising major U.S. financial companies and a host of higher-education institutions.

Mike Stenglein, the leader of the global construction and engineering disputes practice at King & Spalding, says the number of $10-plus billion projects in the world is proliferating, as are disputes over them.

"In some ways, parties understood that no one was to blame and all parties needed to work through the issues together as there were no good options," said Miami managing partner Javier Lopez.

In a patent showdown between rivals in the network security space, jurors sided with Kirkland's Adam Alper and Mike De Vries by finding that their client APCON didn't infringe and that all asserted claims were invalid.

Orrick, Latham, Wilmer and Willkie all land runners-up nods.

The decision, on an issue of first impression, was generally seen as a win for plaintiffs, who may now establish an injury based on an "increased risk" of harm once their sensitive data has leaked.

The firms said they have "agreed to resolve the matter in the interest of expediency."

According to public opinion polls, Americans' opinions about pharmaceutical companies have grown much more positive over the past year. Will that change how it and other industries are viewed as defendants?